Anne Paakinaho
Project Researcher
Pharmacist (MSc), BSc (Biosciences)
School of Pharmacy, Faculty of Health Sciences
anne.paakinaho@uef.fi | +358 40 355 3986
Research groups
Publications
7/7 items-
Disease-modifying antirheumatic drugs and inhaled β2-adrenoceptor agonists and risk of Parkinson’s disease: a nationwide register-based study
Paakinaho, Anne. 2024. Publications of the University of Eastern Finland. Dissertations in Health Sciences -
Statin use and the risk of Parkinson's disease in persons with diabetes: A nested case–control study
Honkamaa, Kim; Paakinaho, Anne; Tolppanen, Anna-Maija; Kettunen, Raimo; Hartikainen, Sirpa; Tiihonen, Miia. 2024. British journal of clinical pharmacology. [Epub ahead of print 13 March 2024]: 1-8 -
Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease
Pirttilä, Aki; Tiihonen, Miia; Paakinaho, Anne; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2023. Journal of the american medical directors association. 24: 1290-1296.e4 -
β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study
Paakinaho, Anne; Tiihonen, Miia; Koskela, Heikki; Koponen, Marjaana; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2023. Clinical epidemiology. 15: 695-705 -
Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease
Paakinaho, Anne; Koponen, Marjaana; Tiihonen, Miia; Kauppi, Markku; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2022. Neurology. 98: e1273-e1281 -
Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control Study
Koponen, Marjaana; Paakinaho, Anne; Lin, Julian; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2022. Clinical epidemiology. 14: 1217-1227 -
Incidence of muscle relaxant use in relation to diagnosis of Parkinson's disease
Paakinaho, Anne; Karttunen, Niina; Koponen, Marjaana; Taipale, Heidi; Tolppanen, Anna-Maija; Hartikainen, Sirpa; Tiihonen, Miia. 2020. International journal of clinical pharmacy. 42: 336-340